Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vandetanib in Treating Patients With Von Hippel-Lindau Syndrome and Kidney Tumors
This study is currently recruiting participants.
Study NCT00566995 Information provided by National Cancer Institute (NCI)
First Received: December 1, 2007 Last Updated: July 22, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Cancer
Von Hippel-Lindau Syndrome
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Kidney Neoplasms
Syndrome
Von Hippel-Lindau Disease
More general conditions related to this trial
Adenocarcinoma
Angiomatosis
Carcinoma
Cardiovascular Diseases
Disease
Kidney Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Nervous System Diseases
Neurocutaneous Syndromes
Pathologic Processes
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Vascular Diseases
Interventions listed in this trial
vandetanib
gene expression analysis
flow cytometry
laboratory biomarker analysis
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
